FindTrial
Sign In

A Clinical Study To See the effect of medicated Ayurvedic eye drops in the management of eye disorders

â??â??A Randomized Clinical Study To Evaluate NAGARAADI ASCHYOTANA in the management of KAPHAJA ABHISHYANDA w.s.r to vernal kerato conjunctivitis,

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/10/021713
Enrollment
30
Registered
2019-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H104- Chronic conjunctivitis Health Condition 2: H104- Chronic conjunctivitis

Interventions

Intervention1: Nagaraadi Aschyotana: Dose - 2 drops four times a day Mode - Aschyotana Duration - 15 days Control Intervention1: sodium chromoglycate drops: Sodium chromoglycate 2% eye drops will be

Sponsors

National Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having age between 5years to 30 years and willing to participate in this study will be selected. Patients presenting with signs and symptoms of KAPHAJA ABHISHYANDA , described as per Ayurvedic and modern science

Exclusion criteria

Exclusion criteria: Patient not willing to participate in study. Cases complicated with corneal pannus ,corneal neovascularisation ,corneal ulcer keratoconus and plaques . Pationt suffering from infective opthalamic disease. Patients suffering from Atopic Kato conjunctivitis ,Giant papillary conjunctivitis and Seasonal Allergic Conjunctivitis . Method of

Design outcomes

Primary

MeasureTime frame
To evaluate Nagaraadi Aschyotana In The management of Kaphaja Abhishyanda W.s.r To vernal kerato Conjunctivitis. Timepoint: 30 days—

Secondary

MeasureTime frame
Any incidental findings if occur during the trial will be recorded and analysedTimepoint: 30 days—

Countries

India

Contacts

Public ContactDr Aparna Sharma

National Institute of Ayurveda

appu07@gmail.com8955688129

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026